The Global NASH/MASH Council (GNC) was pleased to collaborate with Qatar Health Congress 2026 to address key topics in MASLD and MASH. The Congress was co-organized under the leadership of Professor Abdel-Naser Elzouki, Chair of the Scientific Committee and a member of the GNC, by the Department of Medicine at Hamad Medical Corporation, in collaboration with the American College of Physicians, Mayo Clinic, and the Royal Colleges of Physicians (Edinburgh, Glasgow, and London), as well as the Global NASH/MASH Council (GNC). The Congress was attended by approximately 2000 participants from Qatar, the Gulf, and across the MENA region and covered a broad range of topics in internal medicine. In collaboration with Qatar Health Congress 2026 and the Steatotic Liver Disease Research Foundation in the MENA region (SLMENA), the GNC organized a dedicated scientific session entitled “From MASLD to MASH: Advances in Diagnosis and Management.” This symposium was highly interactive and featured presentations on MASH delivered by GNC members from the region. In addition, Zobair Younossi delivered a state-of-the-art lecture entitled “The Growing Burden of MASLD and Its Management in 2026: Challenges, Innovations, and Future Directions.” The GNC is delighted to support this very important region of the world in all our activities.
